Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRE Plus Gamma-Delta T Cells in Pancreatic Cancer
NCT03180437Phase 2Completed
- Sponsor
- Fuda Cancer Hospital
- Start
- Jun 2017
- Primary completion
- Jun 2018
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of gamma-delta T cells in pancreatic cancer (PC), sponsored by Fuda Cancer Hospital. Started Jun 2017; status: completed.
02
Drugs
gamma-delta T cells
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT03180437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03180437.